Full text
IN THE UNITED STATES DISTRICT COURT
FOR THE NORTHERN DISTRICT OF TEXAS
NAVY SEALS 1-26, et al.,
Plaintiffs,
v.
LLOYD J. AUSTIN, III, in his official capacity as
United States Secretary of Defense, et al.,
Defendants.
Case No. 4:21-cv-01236-O
DEFENDANTS’ APPENDIX TO DEFENDANTS’ OPPOSITION
TO PLAINTIFFS’ MOTION FOR A CLASS-WIDE PRELIMINARY INJUNCTION
Table of Appendix
Bates Stamps
Description
App001–App018
Ex. 1 - Declaration of Admiral Daryl L. Caudle
App019–App024
Ex. 2 - Declaration of Vice Admiral William Merz
App025–App035
Ex. 3 - Declaration of Captain Joon Yun
App036–App043
Ex. 4 - Declaration of Rear Admiral Gayle D. Shaffer
Dated: February 23, 2022
Respectfully submitted,
BRIAN M. BOYNTON
Principal Deputy Assistant Attorney General
ALEXANDER K. HAAS
Director, Federal Programs Branch
ANTHONY J. COPPOLINO
Deputy Director
/s/Amy E. Powell
ANDREW E. CARMICHAEL
AMY E. POWELL
Senior Trial Counsel
STUART J. ROBINSON
Senior Counsel
ZACHARY A. AVALLONE
COURTNEY D. ENLOW (NC Bar No. 46578)
LIAM HOLLAND
Trial Attorneys
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 1 of 46 PageID 4108
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 1 of 46 PageID 4108
United States Department of Justice
Civil Division, Federal Programs Branch
1100 L Street, N.W.
Washington, DC 20005
Tel: (202) 616-8467
Fax: (202) 616-8470
Email: courtney.d.enlow@usdoj.gov
Counsel for Defendants
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 2 of 46 PageID 4109
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 2 of 46 PageID 4109
CERTIFICATE OF SERVICE
I hereby certify that on February 23, 2022, I electronically filed the foregoing paper with the
Clerk of Court using this Court’s CM/ECF system, which will notify all counsel of record of such
filing.
/s/Amy Powell
AMY E. POWELL
Senior Trial Counsel
United States Department of Justice
Civil Division, Federal Programs Branch
150 Fayetteville St, Suite 2100
Raleigh, NC 27601
Tel: (919) 856-4013
Fax: (202) 616-8470
Email: amy.powell@usdoj.gov
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 3 of 46 PageID 4110
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 3 of 46 PageID 4110
Exhibit 1
App001
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 4 of 46 PageID 4111
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 4 of 46 PageID 4111
App002
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 5 of 46 PageID 4112
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 5 of 46 PageID 4112
App003
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 6 of 46 PageID 4113
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 6 of 46 PageID 4113
App004
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 7 of 46 PageID 4114
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 7 of 46 PageID 4114
App005
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 8 of 46 PageID 4115
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 8 of 46 PageID 4115
App006
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 9 of 46 PageID 4116
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 9 of 46 PageID 4116
App007
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 10 of 46 PageID 4117
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 10 of 46 PageID 4117
App008
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 11 of 46 PageID 4118
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 11 of 46 PageID 4118
App009
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 12 of 46 PageID 4119
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 12 of 46 PageID 4119
App010
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 13 of 46 PageID 4120
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 13 of 46 PageID 4120
App011
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 14 of 46 PageID 4121
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 14 of 46 PageID 4121
App012
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 15 of 46 PageID 4122
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 15 of 46 PageID 4122
App013
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 16 of 46 PageID 4123
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 16 of 46 PageID 4123
App014
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 17 of 46 PageID 4124
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 17 of 46 PageID 4124
App015
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 18 of 46 PageID 4125
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 18 of 46 PageID 4125
App016
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 19 of 46 PageID 4126
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 19 of 46 PageID 4126
App017
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 20 of 46 PageID 4127
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 20 of 46 PageID 4127
App018
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 21 of 46 PageID 4128
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 21 of 46 PageID 4128
Exhibit 2
App019
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 22 of 46 PageID 4129
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 22 of 46 PageID 4129
App020
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 23 of 46 PageID 4130
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 23 of 46 PageID 4130
App021
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 24 of 46 PageID 4131
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 24 of 46 PageID 4131
App022
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 25 of 46 PageID 4132
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 25 of 46 PageID 4132
App023
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 26 of 46 PageID 4133
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 26 of 46 PageID 4133
App024
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 27 of 46 PageID 4134
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 27 of 46 PageID 4134
Exhibit 3
App025
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 28 of 46 PageID 4135
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 28 of 46 PageID 4135
App026
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 29 of 46 PageID 4136
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 29 of 46 PageID 4136
App027
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 30 of 46 PageID 4137
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 30 of 46 PageID 4137
App028
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 31 of 46 PageID 4138
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 31 of 46 PageID 4138
App029
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 32 of 46 PageID 4139
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 32 of 46 PageID 4139
App030
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 33 of 46 PageID 4140
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 33 of 46 PageID 4140
App031
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 34 of 46 PageID 4141
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 34 of 46 PageID 4141
Exhibit A to CAPT Yun Declaration
App032
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 35 of 46 PageID 4142
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 35 of 46 PageID 4142
1.
Data concerning health to force/personnel
•
Transmission rates, especially comparisons of vaccinated/unvaccinated, and especially if known WRT known ship outbreaks
In the early days of the pandemic, there were no vaccines available. At that time, the US Navy experienced several significant COVID-19
outbreaks aboard ships causing widespread mission disruption, hospitalizations and a death. Restriction of Movement (ROM) policies such as
pre-deployment ROM-Sequester, isolation and quarantine, as well as widespread aggressive testing policies were enacted to prevent COVID-19
introduction onto ships so as to preserve mission capability. The costs in terms of lost duty time and diversion of assets for testing were
extensive. COVID-19 rates were significantly reduced with the introduction of vaccination, allowing for the elimination of ROM-sequester and
ship-wide testing strategies.
Figure 1.
App033
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 36 of 46 PageID 4143
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 36 of 46 PageID 4143
By September 2021, SARS-CoV-2 infection rates among unvaccinated personnel were approximately four times that of vaccinated personnel
(Figure 1). Importantly, severity of disease was also dramatically reduced. Figure 2 below, current through 8 Feb2022, shows the total numbers
of cases, hospitalizations, and deaths by vaccination status. There is a clear reduction in both hospitalizations and deaths with vaccination
status, with no deaths occurring in fully vaccinated US Navy or Marine Corps personnel and only ten hospitalizations (4 US Navy, 6 US Marine
Corps).
Figure 2.
Number
of
COVID-19
Cases
%
Number
of
COVID-19
Cases
%
Number
of
COVID-19
Cases
%
Vaccination Status¹
Severe Case²
No
Yes-Hospitalized
78
0.29%
96
0.21%
174
0.24%
Yes-Death
2
0.01%
8
0.02%
10
0.01%
No
15,050
55.33%
27,035
60.44%
42,085
58.51%
Yes-Hospitalized
6
0.02%
4
0.01%
10
0.01%
Yes-Death
0
0.00%
0
0.00%
0
0.00%
No
390
1.43%
1,931
4.32%
2,321
3.23%
Yes-Hospitalized
0
0.00%
0
0.00%
0
0.00%
Yes-Death
0
0.00%
0
0.00%
0
0.00%
27,200
100.00%
44,729
100.00%
71,929
100.00%
Prepared by the EpiData Center Department, Navy and Marine Corps Public Health Center, 09FEB2022.
All hospitalized cases among fully immunized and boosted service members are manually reviewed by a clinician. Hospitalizations among not fully immunized service members are not manually reviewed.
Department of the Navy Active Duty: Total COVID-19 Case Occurrence by Vaccination Status¹
17DEC2020-08FEB2022
¹ Two vaccine doses were considered complete for the Pfizer-BioNTech and Moderna COVID-19 vaccines, and one vaccine dose was considered complete for the J&J/Janssen COVID-19 vaccine.
Individuals were considered fully vaccinated 14 days after receipt of the final dose. An individual was considered not fully immunized if they did not receive any vaccine doses, have only received a partial
series, or have not yet reached 14 days after the completion of their vaccine series. COVID-19 vaccines with an error in the Medical Readiness Reporting System were removed from this analysis.
² Severe COVID-19 case defined as hospitalization or death reported in the Armed Forces Health Surveillance Division COVID-19 Master Positive List.
Data Source: Medical Readiness Reporting System, Armed Forces Health Surveillance Division COVID-19 Master Positive List.
37.99%
Not fully immunized¹ prior to the COVID-19 incident
date
Fully immunized¹ but not boosted: COVID-19 incident
date >=14 days after final dose of regular series, no
booster
Boosted: COVID-19 incident date >=7 days after
receiving booster
Total
11,674
42.92%
15,655
35.00%
27,329
Vaccination Status¹ and Severity²
Service
Total
Marine Corps
Navy
App034
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 37 of 46 PageID 4144
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 37 of 46 PageID 4144
App035
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 38 of 46 PageID 4145
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 38 of 46 PageID 4145
Exhibit 4
App036
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 39 of 46 PageID 4146
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 39 of 46 PageID 4146
App037
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 40 of 46 PageID 4147
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 40 of 46 PageID 4147
App038
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 41 of 46 PageID 4148
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 41 of 46 PageID 4148
App039
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 42 of 46 PageID 4149
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 42 of 46 PageID 4149
App040
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 43 of 46 PageID 4150
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 43 of 46 PageID 4150
App041
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 44 of 46 PageID 4151
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 44 of 46 PageID 4151
App042
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 45 of 46 PageID 4152
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 45 of 46 PageID 4152
App043
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 46 of 46 PageID 4153
Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 46 of 46 PageID 4153